SCHEMBL5067602

SCHEMBL5067602

CCOC(=O)c1ccc(N(C)CCCN(C)C)nn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.42
▸ ALDH1A1 P00352 3/20 0.39
▸ POLB P06746 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ RAD52 P43351 2/20 0.38
▸ UHRF1 Q96T88 1/20 0.38
▸ GAA P10253 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ DRD4 P21917 1/20 0.36
▸ HTR1D P28221 1/20 0.36
▸ HTR1B P28222 1/20 0.36
▸ HTR1F P30939 1/20 0.36
▸ HTR7 P34969 1/20 0.36
▸ DRD3 P35462 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17984648 0.81 CYP1A2 (0.50) CYP1A2ALDH1A1POLBKMT2AGAA
SCHEMBL6279338 0.81 CYP1A2 (0.38) CYP1A2ALDH1A1POLBKMT2ARAD52
SCHEMBL6279336 0.80 TP53 (0.42) CYP1A2ALDH1A1POLBKMT2ARAD52
SCHEMBL5642066 0.77 CYP1A2 (0.64) CYP1A2ALDH1A1POLBKMT2AGAA
SCHEMBL5067600 0.75 POLB (0.42) CYP1A2ALDH1A1POLBKMT2ARAD52
SCHEMBL16132008 0.73 HRH3 (0.35) ALDH1A1POLBKMT2AKDM4EPIM2
SCHEMBL4040622 0.72 CYP1A2 (0.41) CYP1A2ALDH1A1KMT2AGAAMAPT
SCHEMBL12132543 0.71 ALDH1A1 (0.56) CYP1A2ALDH1A1POLBGAAKDM4E
SCHEMBL29524945 0.71 CYP1A2 (0.56) CYP1A2ALDH1A1POLBKMT2AGAA
SCHEMBL13197220 0.71 CYP1A2 (0.56) CYP1A2ALDH1A1POLBKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384952-B2 Pyrazolopyrimidine compound and a process for preparing the same MITSUBISHI TANABE PHARMA CORPORATION (JP) 2008-06-10 — — US disclosed
EP-1857459-A2 Pyrazolopyrimidine compound and a process for preparing the same TANABE SEIYAKU CO., LTD. (JP) 2007-11-21 — — EP disclosed
US-20060135525-A1 Pyrazolopyrimidine compound and a process for preparing the same MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135525-A1 Pyrazolopyrimidine compound and a process for preparing the same KCNJ2, KCNN2, KCNH2 CYP1A2 303/4885ALDH1A1 2470/4885POLB 2895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback